Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Mikael Dolsten MD, PhD
Age : 58
Public asset : 12,135,537 USD
Linked companies : Pfizer Inc. - Karyopharm Therapeutics Inc
Dr. Mikael Dolsten is President-Worldwide Research & Development at Pfizer Inc., Governor at New York Academy of Sciences and a Member at Government-University-Industry Research Roundtable.

He is on the Board of Directors at Karyopharm Therapeutics, Inc., PhRMA Foundation and The New York Hall of Science. Dr. Dolsten was previously employed as Senior Vice President by Wyeth Corp., President by Wyeth Research, a Principal by OrbiMed Advisors LLC, Partner by OrbiMed Advisors Private Equity, EVP, Global Head-Pharma Research & Discovery by Boehringer Ingelheim Pharmaceuticals, Inc., and Member-Benefits, Law & Regulatory Committee by Wyeth Pharmaceuticals, Inc.

He received his doctorate degree from the University of Lund.

Current positions of Mikael Dolsten MD, PhD 
NameTitle Since
Karyopharm Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2015
New York Academy of Sciences Governor -
The New York Hall of Science Trustee -
PhRMA Foundation Director -
Pfizer Inc.
President-Worldwide Research & Development 2009
Government-University-Industry Research Roundtable Member -

Holdings of Mikael Dolsten MD, PhD 
Pfizer (PFE)
339,9310.0057%12,135,537 USD
Karyopharm Therapeutics Inc (KPTI)
Biotechnology & Medical Research
00.0000%0 USD

Mikael Dolsten MD, PhD: Personal Network 

Most Read News 
10/17DJSUMNER REDSTONE : Redstone's Ex-Companion Sues His Daughter, Grandson
04:11a WILLIAM ACKMAN : Ackman urges ADP to consider acquiring Ceridian amid proxy fight
10/17DJWARREN BUFFETT : Top Company News of the Day
10/19 DAVID HENRY : U.S. bankers hold onto hopes that Trump will boost profits
10/17 FRANCK RIBOUD : Riboud to stand down as Danone chairman - Le Monde
10/13 DAVID HENRY : JPMorgan's card gamble lures millennial travelers, squeezes competitors
10/17DJRONNIE LETEN : Investor Net Asset Value Rises 1.4% on Quarter in Third Quarter
10/16DJJACK MA : China's Xi Approaches a New Term With a Souring Taste for Markets
10/19 IGOR SECHIN : Rosneft's Sechin says no watershed in oil market, U.S. shale oil a risk
10/18 RICHARD BRANSON : Billionaire Branson targeted in $5 million scam 'straight out of le Carre'
More news

© 2017 People and Ownership :   
Mikael Dolsten MD, PhD : Connections 
The Paley Center for Media (New York)
The New York Hall of Science
Boston Properties LP
Satmap, Inc.
Metamark Genetics, Inc.
Pace University
Cellco Partnership, Inc.
Vicarious Surgical, Inc.
Perella Weinberg Partners Group LP
On-Ramp Wireless, Inc.

Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Vincent Bolloré John Bryant Warren Buffett Kenneth Chenault Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth John Edwards Douglas Flint Kenneth Frazier Carlos Ghosn Mario Greco Stuart Gulliver David Henry Carl Icahn Joseph Jimenez Dara Khosrowshahi Daniel Loeb Jack Ma James Murdoch Elon Musk Michael O'leary John Paulson Nelson Peltz Wolfgang Porsche Thomas Rabe Franck Riboud Alexandre Ricard Xavier Rolet Wilbur Ross Sheryl Sandberg Rolf Martin Schmitz Vishal Sikka Carlos Slim George Soros Ulrich Spiesshofer Rupert Stadler Johannes Teyssen John Watson Meg Whitman Guy Wyser-pratte Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders